Status:
UNKNOWN
Transcutaneous Bilirubin Measurements in Neonates Post Phototherapy
Lead Sponsor:
NHS Greater Glasgow and Clyde
Conditions:
Jaundice, Neonatal
Eligibility:
All Genders
1-14 years
Phase:
NA
Brief Summary
Can transcutaneous bilirubin (TcB) measurements be utilised to assess rebound hyperbilirubinaemia following phototherapy in neonates?
Detailed Description
Jaundice is common in the newborn and may result in the need for babies to be readmitted from home for phototherapy, with associated increased costs and significant family distress. As well as prolon...
Eligibility Criteria
Inclusion
- Well neonates
- 35+0 weeks gestation or greater, over 24 hours old
- Inpatients at Princess Royal Maternity (PRM), NHS Greater Glasgow and Clyde
Exclusion
- Unwell neonates
- Less than 35+0 weeks' gestation
- Less than 24 hours old
- Mother unable or too distressed to give informed consent
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04719104
Start Date
April 1 2021
End Date
October 1 2021
Last Update
January 22 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.